Reply to "Tachycardia, adverse effect, COVID-19 vaccine".

Teresa Marco García, M; Lana, Álvaro Torres; Berta Anta Agudo, M; de la Trinidad Rufino Delgado, M

Teresa Marco García, M; Lana, Álvaro Torres; Berta Anta Agudo, M; de la Trinidad Rufino Delgado, M.

Teresa Marco García M; Gerencia de Atención Primaria de Tenerife, Servicio Canario de Salud, Spain. Electronic address: mmargart@gobiernodecanarias.org.
Lana ÁT; Dirección General de Salud Pública, Servicio Canario de Salud, Spain.
Berta Anta Agudo M; Gerencia de Atención Primaria de Tenerife, Servicio Canario de Salud, Spain.
de la Trinidad Rufino Delgado M; Gerencia de Atención Primaria de Tenerife, Servicio Canario de Salud, Spain.

Enferm Infecc Microbiol Clin (Engl Ed) ; 41(1): 65-66, 2023 01.

Article in English | MEDLINE | ID: covidwho-2236213

Subject(s)

COVID-19 Vaccines; COVID-19; Humans; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Drug-Related Side Effects and Adverse Reactions; Tachycardia

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Enferm Infecc Microbiol Clin (Engl Ed) Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google